LipskaK, HirschIB, RiddleMC: Human insulin use for type 2 diabetes: An effective, less expensive option. JAMA, 2017; 318:23–24.
2.
EdelmanSV, PolonskyWH: Type 2 diabetes in the real world: The elusive nature of glycemic control. Diabetes Care, 2017; 40:1425–1432.
3.
DaveCV, KesselheimAS, FoxER, QiuP, HartzemaA: High generic drug prices and market competition: A retrospective cohort study. Ann Intern Med, 2017; 167:145–151.
Associated Press: Drug prices don't budge even after pressure from Congress. STAT, November 16, 2016 https://www.statnews.com/2016/11/16/drug-prices-congress-pressure/. Accessed January1, 2018.
KingR: HHS nominee Alex Azar takes heat for raising insulin prices. Washington Examiner. November 29, 2017.
9.
CarterAW, HeinemannL: Insulin concentration in vials randomly purchased in pharmacies in the United States: considerable loss in the cold supply chain. J Diabetes Sci Technol [e-pub ahead of print] December 1, 2017.
10.
GingrichN: “Winning the Future”. Regery Publishing. 2005.
11.
MarsoSP, DanielsGH, Brown-FrandsenK, KristensenP, MannJFE, NauckMA, NissenSE, PocockS, PoulterNR, RavnLS, SteinbergWM, StocknerM, ZinmanB, BergenstalRM, BuseJB, for the LEADER Steering Committee on behalf of the LEADER TrialInvestigators: Liraglutide and cardiovascular outcomes in type 2 diabetes. N Engl J Med, 2016; 375:311–322.
12.
MarsoSP, BainSC, ConsoliA, EliaschewitzFG, JodarE, LeiterLA, LingvayI, RosenstockJ, SeufertJ, WarrenML, WooV, HansenO, HolstAG, PetterssonJ, VilsbøllT, for the SUSTAIN-6 Investigators: Semaglutide and cardiovascular outcomes in patients with type 2 diabetes. N Engl J Med, 2016; 375:1834–1844.
13.
NealB, PerkovicV, MahaffeyKW, de ZeeuwD, FulcheG, EronduN, ShawW, LawG, DesaiM, MatthewsDR, for the CANVAS Program CollaborativeGroup: Canagliflozin and cardiovascular and renal events in type 2 diabetes. N Engl J Med, 2017; 377:644–657.
14.
American Diabetes Association: Pharmacologic approaches to glycemic treatment: Standards of medical care in diabetes-2018. Diabetes Care, 2018; 41(Suppl 1):S73–S85.
